These findings not only shed new light on the molecular mechanisms governing muscle fiber remodeling but also highlight the therapeutic potential of lncRNA‐MEG3 for combating muscle‐wasting conditions, such as Duchenne muscular dystrophy. Here, MEG3 is linked to Duchenne muscular dystrophy.